Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
Volume 0.68M
Average 0.41M
SPTX Weighted Avg Shares (Diluted)
Average shares outstanding including dilutive securities, used to calculate diluted EPS.
Weighted Avg Shares (Diluted) history
Shares · from the income statement
No Weighted Avg Shares (Diluted) data reported for this period type.
Weighted Avg Shares (Diluted) vs competitors
How SPTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
NMRANeumora Therapeutics, Inc. Common Stock | LTM Mar 2026 | 166.7M | +4.0% | +2.4% |
| LTM Mar 2026 | 62.03M | +15.9% | +5.5% | |
| LTM Mar 2026 | 59.11M | +1.3% | +1.1% | |
| LTM Mar 2026 | 43.04M | +3.9% | +2.0% | |
RAPPRapport Therapeutics, Inc. Common Stock | LTM Mar 2026 | 41.9M | +115.2% | +32.7% |
CTNMContineum Therapeutics, Inc. Class A Common Stock | LTM Mar 2026 | 30.55M | +18.4% | +3.3% |
LBRXLB Pharmaceuticals Inc Common Stock | LTM Mar 2026 | 19.77M | — | +92.6% |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — |
| Peer median (excluding SPTX) | 43.04M | +10.0% | +3.3% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.